Lv1
40 积分 2021-05-13 加入
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
4个月前
已完结
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
5个月前
已完结
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer
8个月前
已完结
FDA analyses of survival in older adults with metastatic non–small cell lung cancer in controlled trials of PD-1/PD-L1 blocking antibodies
8个月前
已完结
Challenges and opportunities in rare cancer research in China
10个月前
已完结
皖公网安备34019202002308
